Standard Biotools Inc (LAB) Live Share Price, Invest From India

Standard Biotools Inc Stock Performance

as on November 5, 2025 at 2:29 am IST

Day's Low
Day's High
$1.17
Day's Price Range
$1.22
$1.2
2.50%
Downside
1.67%
Upside
52 Week's Low
52 Week's High
$0.92
52-Week Price Range
$2.32
$1.2
23.33%
Downside
93.33%
Upside

Standard Biotools Inc share price movements today

Previous Close: $1.24
Open: $1.19
Volume: 1.4M
Day's Low - High: $1.17 - $1.22
52 Week Low - High: $0.92 - $2.32

Standard Biotools Inc Historical Returns

1 Month Return: -11.19 %
3 Month Return: -8.46 %
1 Year Return: -43.6 %
3 Year Return: + 6.25 %
5 Year Return: 0 %

Standard Biotools Inc Stock Fundamentals & Key Indicators

Check Standard Biotools Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$473.7M

EPS (TTM)

-0.09

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.69

Industry PE ratio

-0.8126129032258065

PEG Ratio

EBITDA

-121.8M

Revenue (TTM)

172.3M

Profit Margin

-69.95%

Return On Equity TTM

-29.54%

Standard Biotools Inc Stock Valuation

Track how Standard Biotools Inc P/E has moved over time to understand its valuation trends.

Standard Biotools Inc in the last 5 years

Overview
Trends

Lowest (-10.58x)

September 30, 2025

Today (-4.69x)

November 5, 2025

Industry (-0.81x)

November 5, 2025

Highest (-0.50x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -4.69x

Standard Biotools Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Standard Biotools Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Standard Biotools Inc	BUY	$473.7M	NA	-4.69	-69.95%
Boston Scientific Corp.	BUY	$146.2B	180.72%	52.72	14.43%
Stryker Corporation	BUY	$137.0B	72.18%	47.19	12.07%
Abbott Laboratories	BUY	$215.3B	10.81%	15.56	31.88%
Edwards Lifesciences Corp.	BUY	$49.4B	8.51%	36.75	23.25%

See all

Stock Returns calculator for Standard Biotools Inc Stock including INR - Dollar returns

The Standard Biotools Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Standard Biotools Inc investment value today

Current value as on today

₹62,223

Returns

₹37,777

(-37.78%)

Returns from Standard Biotools Inc Stock

₹43,128 (-43.13%)

Dollar Returns*

₹5,351 (+5.35%)

Analyst Recommendation on Standard Biotools Inc Stock

Based on 6 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 6 analysts, 83.33% of analysts recommend a 'BUY' rating for Standard Biotools Inc. Average target price of $1.77

Standard Biotools Inc Share Price Target

Get share price movements and forecasts by analysts on Standard Biotools Inc.

What analysts predicted

32.2%UPSIDE

Target Price

$1.77

Current Price

$1.2

Analyzed by

6 Analysts

Target

$1.77

Standard Biotools Inc target price $1.77, a slight upside of 32.2% compared to current price of $1.2. According to 6 analysts rating.

Standard Biotools Inc Stock’s Investor Sentiment and Interest

Search interest for Standard Biotools Inc Stock has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.

Time period: October 6, 2025 to November 5, 2025

Change:-63% versus previous 30 day period

Standard Biotools Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	25	27	25	28	45	37	44	46	40	21
Gross Profit	12	13	11	13	24	14	23	21	19	1
Operating Income	-16	-17	-21	-14	-60	-50	-31	-32	-32	-19
EBITDA	-11	-11	-15	-14	-26	-41	-23	-29	-22	-16
Interest Expense	1	1	1	1	1	0	-	3	0	0
Depreciation	3	3	3	3	5	3	3	3	4	3
Income Before Tax	-16	-16	-20	-19	-32	-45	-26	-33	-26	-15
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-16	-17	-20	-19	-32	-45	-26	-34	-26	-33
Net Profit Margin	-67.05%	-61.59%	-82.77%	-70.16%	-70.61%	-122.88%	-59.90%	-72.93%	-63.81%	-153.75%

Standard Biotools Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	114	104	101	112	117	138	130	97	106	174
Gross Profit	68	58	51	61	64	83	77	37	50	84
Operating Income	-50	-73	-58	-48	-51	-51	-67	-116	-76	-175
EBITDA	-32	-56	-39	-31	-46	-32	-44	-173	-54	-118
Interest Expense	5	5	5	13	4	3	3	4	4	3
Depreciation	-	-	-	16	15	15	15	15	14	16
Income Before Tax	-54	-80	-63	-61	-66	-54	-63	-192	-74	-138
Income Tax Expense	-1	-4	-3	-2	-1	-1	-4	-2	0	0
Net Income	-53	-75	-60	-59	-64	-53	-59	-190	-74	-138
Net Profit Margin	-46.48%	-72.75%	-59.38%	-52.24%	-55.26%	-38.38%	-45.36%	-194.08%	-70.21%	-79.62%

Standard Biotools Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-17	-20	-19	-32	-45	-26	-34	-26	-33
Operating Cash Flow	-9	-11	-14	-62	-39	-27	-14	-30	-20
Investing Cash Flow	40	-49	-13	318	50	-30	25	14	27
Financing Cash Flow	-2	-1	-1	-19	-28	0	-54	0	0
Change in Cash	28	-62	-27	235	-17	-59	-43	-15	7

Standard Biotools Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-75	-60	-59	-64	-53	-59	-190	-74	-138
Operating Cash Flow	-39	-24	-25	-35	-15	-44	-89	-43	-143
Investing Cash Flow	45	17	4	-39	39	-11	-88	20	363
Financing Cash Flow	0	28	57	2	20	15	230	-6	-102
Change in Cash	5	23	37	-71	45	-40	52	-29	116

Insights on Standard Biotools Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Edwards Lifesciences Corp. has given 26.2% return, outperforming this stock by 69.8%
NO EFFECT
Against Peers
In the last 3 years, Boston Scientific Corp. has given 22.8% return, outperforming this stock by 16.6%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 46.71M → 21.76M (in $), with an average decrease of 29.7% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -26.03M → -33.45M (in $), with an average decrease of 28.5% per quarter
NEGATIVE IMPACT
Price Dip
In the last 1 year, LAB stock has moved down by -43.6%

About Standard Biotools Inc

fluidigm (nasdaq:fldm) develops, manufactures and markets microfluidic systems for growth markets in the life sciences and in applied markets. fluidigmâ€™s systems consist of instruments, software, integrated fluidic circuits (ifcs), high-performance assays for gene expression and genotyping, and primers for sample preparation for next-generation sequencing. fluidigm technology enables customers to perform thousands of sophisticated biochemical measurements in parallel on samples smaller than the content of a single cell, with nanoliter volumes of reagents, in half the area of a credit card. the companyâ€™s integrated customer solutions are designed to significantly simplify experimental workflows, increase throughput and reduce costs while delivering excellent data quality. based in south san francisco, fluidigm offers an exciting and collegial working environment with excellent compensation and benefits, including equity.

Organisation	Standard Biotools Inc
Headquarters	2 Tower Place, South San Francisco, CA, United States, 94080
Industry	Technology
CEO	Dr. Michael Egholm Ph.D.
E-voting on shares	Click here to vote

Key Management of Standard Biotools Inc

Name	Title
Dr. Stephen A. Williams BS, MB, Ph.D.	Chief Medical Officer
Mr. Mike Musgnug	Senior VP & Chief Commercial Officer
Dr. Michael Egholm Ph.D.	President, CEO & Director
Mr. Hanjoon Kim	Chief Financial Officer
Mr. Sean Mackay	Chief Business Officer & Senior VP
Mr. Jonathan Mickelsen	VP & Chief Accounting Officer
John Graziano	Vice President of Investor Relations
Ms. Elizabeth R. Jensen	Chief Human Resources Officer

FAQs

What is Standard Biotools Inc share price today?

Standard Biotools Inc share price today is $1.2 as on November 5, 2025 at 2:29 am IST at the close of the market. Standard Biotools Inc share today touched a day high of $1.22 and a low of $1.17.

What is the 52 week high and 52 week low for Standard Biotools Inc share?

Standard Biotools Inc share touched a 52 week high of $2.32 on November 7, 2024 and a 52 week low of $0.92 on May 23, 2025. Standard Biotools Inc stock price today i.e. November 5, 2025 at 2:29 am IST is closed at $1.2,which is 48.28% down from its 52 week high and 30.43% up from its 52 week low.

What is Standard Biotools Inc's market capitalisation today?

Standard Biotools Inc market capitalisation is $0.00T as on November 5, 2025 at 2:29 am IST.

How to invest in Standard Biotools Inc Stock (LAB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Standard Biotools Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Standard Biotools Inc Shares that will get you 1.2500 shares as per Standard Biotools Inc share price of $1.2 per share as on November 5, 2025 at 2:29 am IST.

What is the minimum amount required to buy Standard Biotools Inc Stock (LAB) from India?

Indian investors can start investing in Standard Biotools Inc (LAB) shares with as little as ₹88.615 or $1 (as of November 5, 2025 at 5:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹886.15 in Standard Biotools Inc stock (as per the Rupee-Dollar exchange rate as on November 5, 2025 at 5:41 pm IST). Based on Standard Biotools Inc share’s latest price of $1.2 as on November 5, 2025 at 2:29 am IST, you will get 8.3333 shares of Standard Biotools Inc. Learn more about fractional shares .